AHCO vs IART โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IART Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Integra LifeSciences Holdings (IART) driven by superior Valuation, Growth & Margin, Momentum & Technical while AHCO counters with relative strength in Options & Structure. Fundamentally, AHCO trades at 7.8x Forward P/E with 3.8% operating margin (+10.9% YoY revenue) versus IART at 5.6x Forward P/E and 9.9% operating margin (+2.3% YoY). In options structure, AHCO sits in SURGE (12th %ile IV; Dealer Gamma Walls on Pro) against IART sits in BREAKDOWN (16th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | AHCO Revenue | IART Revenue | AHCO Op. Margin | IART Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $350M | $1.47B | 9.0% | 7.5% | AHCO |
| FY2019 | $530M | $1.52B | 5.5% | 6.2% | IART |
| FY2020 | $1.06B | $1.37B | 6.8% | 11.0% | IART |
| FY2021 | $2.45B | $1.54B | 9.2% | 12.8% | IART |
| FY2022 | $2.97B | $1.56B | 6.4% | 15.3% | IART |
| FY2023 | $3.20B | $1.54B | -18.7% | 7.2% | IART |
| FY2024 | $3.26B | $1.61B | 8.1% | 1.8% | AHCO |
| FY2025 | $3.24B | $1.64B | 2.8% | -30.2% | AHCO |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AHCO | IART | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $989.8M | $1.1B | Larger Scale | IART |
| Trailing P/E Ratio Valuation | 7.8x | 79.7x | Lower Multiple | AHCO |
| Forward P/E Ratio Valuation | 7.8x | 5.6x | Lower Multiple | IART |
| Revenue Growth (YoY) Growth | +10.9% | +2.3% | Higher Growth | AHCO |
| Operating Margin (TTM) Profitability | 3.8% | 9.9% | Higher Margin | IART |
| Net Profit Margin Profitability | -11.8% | 0.8% | Higher Margin | IART |
| Return on Equity (ROE) Capital Efficiency | -28.4% | 1.2% | Higher ROE | IART |
| 52-Week Range Position Momentum | 24% ($5โ$13) | 39% ($9โ$20) | Stronger Trend | IART |
| Beta / 30D Volatility Risk Regime | 0.17ฮฒ ยท 67% Vol | 1.54ฮฒ ยท 60% Vol | Lower Realized Risk | IART |
| Unified Institutional Score Composite Signal | 45.2 / 100 (HOLD) | 45.5 / 100 (HOLD) | Higher Composite | IART |